Colgate-Palmolive (India) Ltd. Share Price

Overview

Colgate-Palmolive (India) Ltd. share price is currently ₹1,775.07, down by - ₹6.87 (0.39%) from its previous closing price of ₹1,781.94. The share price has declined -10% over the past month and declined -26.16% over the past year. The stock's 52-week low and high are ₹1,759.40 and ₹2,356.45, respectively. Colgate-Palmolive (India) Ltd. has a market capitalisation of ₹ 49,750.00 Cr. The share price was last updated on 11 Sep 2026, 03:54 PM IST.

Colgate-Palmolive (India) Ltd.
Colgate-Palmolive (India) Ltd.
COLPAL
 0.00
- 6.87
0.39%
FMCG
 0.00(%)1D

Updated: 11 Sep 2026, 03:54:14 pm IST

Market Data

Open Price

 1,786.21

Prev. Close

 1,781.94
 1,759.40

Day Low

 1,786.21

Day High

 1,759.40

52 Week Low

 2,356.45

52 Week High

FMCGHousehold & Personal Products
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

35.82

Sector PE

31.03

PB Ratio

30.14

Sector PB

7.18

EPS

49.55

Dividend Yield

2.68

Today's Volume

287.599 K

5 Day Avg. Volume

289.325 K

PEG Ratio

-4.62

Market Cap.

₹ 49,750.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsInterim Dividend of 2400% at ₹24/Share
01-Jun-202601-Jun-2026
DividendsInterim Dividend of 2400% at ₹24/Share
03-Nov-202503-Nov-2025
DividendsInterim Dividend of 2700% at ₹27/Share
28-May-202528-May-2025
DividendsInterim Dividend of 2400% at ₹24/Share
04-Nov-202404-Nov-2024

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
SBI Large & Midcap Fund - Regular Plan - IDCW41.61 Lac
41.61 Lac
no change
Nippon India Multi Cap Fund - Growth16.93 Lac
20.54 Lac
(21.33%)
SBI Midcap Fund - Regular Plan - Growth18.00 Lac
18.00 Lac
no change
Nippon India Large Cap Fund - Growth15.29 Lac
15.90 Lac
(4.04%)
Nippon India Growth Mid Cap Fund - Growth Option13.00 Lac
13.00 Lac
no change

About Colgate-Palmolive (India) Ltd. 👋

Colgate-Palmolive (India) Limited is primarily focused on development and manufacture of oral care and personal care in the Indian market. The Company manufactures and markets a range of oral care essentials under the Colgate brand, including toothpastes, toothpowder, toothbrushes, mouthwashes and rinses, and specialty products such as professional grade oral care products. Additionally, its Palmolive brand offers a specialized range of personal care products. Its products include New MaxFresh Range, Lemon Fresh, CST New Formula with New Flavor and Colgate Visible White Purple. The Colgate brand includes Colgate Total, Colgate Visible White and Colgate Strong Teeth, Peppermint Mouthwash and others. Its products include White Purple Toothpaste, Kids Premium Toothpaste Baby Natural Fruit. It collaborates through its distributor's network or otherwise with a network of diverse wholesalers, modern trade stores, e-commerce and other retailers to make their products available to customers.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
MBA Investmentwala

MBA Investmentwala

13 Sep • 1:17 PM · SEBI-Registered Analyst

Potential Divestment Could Reshape Colgate's Brand Portfolio

COLPAL
Colgate-Palmolive is exploring the sale of select mass-market personal-care brands, including Softsoap, Irish Spring and Speed Stick, according to Reuters sources. The selected brands could collectively fetch more than $1 billion if a transaction is completed. Goldman Sachs has been engaged to advise Colgate-Palmolive on the potential divestment process. The company is not looking to exit its entire personal-care business; the review covers only selected brands within the portfolio. Colgate-Palmolive and Goldman Sachs have not publicly commented on the potential transaction, meaning the process remains exploratory. Strategic Rationale Behind the Potential Brand Sale: Colgate's broader personal-care business accounted for approximately 17% of company-wide sales in 2025, equivalent to roughly $3.5 billion. A divestment could allow Colgate to concentrate resources on higher-priority and potentially faster-growing brands and categories. Proceeds from a potential sale could provide additional financial flexibility for investment, debt management, shareholder returns or portfolio restructuring. The move comes amid broader portfolio optimisation across global consumer-goods companies as businesses respond to tariffs, higher input costs and changing consumer spending patterns.

See More
Sohrab Shaikh (SEBI RA)

Sohrab Shaikh (SEBI RA)

31 Aug • 11:09 PM · SEBI-Registered Analyst

Higher delivery stocks as on 31st August, 2026

Stock Delivered Qty Avg Qty ASTRAL 8813026 251885 BALKRISIND 6210566 245938 SBICARD 22645710 1002897 LTTS 425293 21113 ADANIENSOL 29550724 1519823 LENSKART 69010168 4271695 ADANIENT 9771644 713420 NAM-INDIA 5479792 423603 LAURUSLABS 24140560 2028262 ETERNAL 236125194 20770392 AIIL 666928 63326 EMBDL 8043132 828638 DALBHARAT 1361987 147223 DOMS 95652 10705 SUNDARMFIN 166059 20146 LATENTVIEW 1433202 198529 RELIANCE 30329813 4484850 ADANIPORTS 7910724 1173180 CRAFTSMAN 128997 19332 COLPAL 812259 122159 RCF 4640153 720082 GMRAIRPORT 50861088 8231092

ASTRAL

See More
Sarathi Research

Sarathi Research

21 Aug • 3:33 PM · SEBI-Registered Analyst

Colgate-Palmolive India Appoints New MD & CEO

COLPAL
Colgate-Palmolive India has appointed Manish Anandani as its new Managing Director and CEO for a five-year ***** appointment follows the resignation of Prabha Narasimhan from the MD & CEO ***** company’s board approved Anandani’s appointment as part of its leadership ***** change comes at an important time as the company focuses on strengthening its personal-care and oral-care ***** will be watching the new management’s strategy for growth and market ***** leadership transition could also bring changes in the company’s business priorities and ***** stock was in focus following the announcement, with shares falling nearly 2% during trading. For traders, the key factor now will be whether the stock stabilises after the initial reaction and develops a fresh technical setup.

See More
Harika Enjamuri

Harika Enjamuri

21 Aug • 9:34 AM · SEBI-Registered Analyst

Colgate-Palmolive India Announces Leadership Transition as Prabha Narasimhan Moves to Global Role

Colgate-Palmolive India is set for a leadership transition, with MD & CEO Prabha Narasimhan stepping down from her current role effective September 27, 2026, to take up a global position as Executive Vice President – Marketing for the company’s Asia Pacific division. She had taken charge as MD & CEO on September 1, 2022, and during her tenure, the company’s shares gained around 14% over the last four years, although the stock has since corrected sharply from its record high of ₹3,893 reached in October 2024 and is currently around 51% below that peak. Manish Anandani, currently Managing Director for India and South Asia at Kenvue, the erstwhile Johnson & Johnson Consumer Health business, has been appointed as the new MD & CEO for a five-year term, subject to shareholder approval. Anandani brings prior experience with Colgate-Palmolive, having joined the company in 2005 as a regional manager and worked across various roles in India and the Indochina region before leaving in 2018 as Worldwide Director in Global Customer Development. He holds a degree in Electronics, an MBD in Marketing and an Executive MBA in Leadership from the Turk School of Business, USA. In early trade on August 21, 2026, Colgate-Palmolive India shares were trading 0.75% lower at ₹1,895.7 and have declined around 10% so far in 2026. From a research perspective, the leadership change marks an important transition for the company, while Anandani’s previous experience with Colgate-Palmolive and his recent leadership role at Kenvue could support continuity as the company moves into its next phase.

COLPAL
Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.

See More
Pavan Rawat

Pavan Rawat

18 Aug • 4:54 PM · SEBI-Registered Analyst

COLGATE-PALMOLIVE INDIA STOCK FALLS 3% AS BROKERAGES TURN CAUTIOUS

COLPAL
Colgate-Palmolive (India) fell more than 3 percent in morning trading today after brokerages adopted a cautious stance on the company’s near-term earnings outlook following its Q1 FY27 results. Concerns are centered on higher investments in advertising, brand building and premiumisation, which could weigh on profitability. The stock was down around 3.1 percent, making it one of the top midcap losers, while it has declined 8.7 percent so far in 2026. The company currently has a market capitalisation of more than Rs 52,000 crore. Analysts expect revenue growth to remain supported by improving volumes, pricing and the company’s focus on premium products. However, they cautioned that higher advertising and brand investments could result in earnings growth lagging revenue growth and limit margin expansion. CLSA retained its Hold rating with a target price of Rs 2,024, noting that Colgate’s strong gross margins provide room for increased advertising expenditure. Around 60 percent of the company’s advertising spending is digital, which is supporting faster growth in premium products. CLSA, however, lowered its earnings estimates to account for higher advertising costs and warned that elevated investments could continue amid intensifying competition. Colgate-Palmolive India reported a 7 percent year-on-year rise in net profit in Q1 FY27, while revenue increased 11.8 percent. EBITDA rose 6.7 percent, although the EBITDA margin narrowed to 31.6 percent from the year-ago quarter. The results indicate healthy top-line momentum, but investors are increasingly focused on whether higher investments in growth and premiumisation can generate stronger earnings without putting sustained pressure on margins. While most brokerages remain cautious, one brokerage maintained a bullish view and sees more than 30 percent potential upside, expecting the company’s increased growth investments to translate into stronger revenue growth over the longer term.

See More
Ashish Kumar

Ashish Kumar

18 Aug • 4:16 PM · SEBI-Registered Analyst

Colgate-Palmolive India shares drop over 3% as brokerages flag growth-margin trade-off

COLPAL
Shares of Colgate-Palmolive India fell more than 3% on Tuesday after the company’s post-Q1 FY27 analyst call, with the stock trading around ₹1,904 in morning deals and ranking among the top midcap losers. The decline came as several brokerages turned cautious on near-term earnings, highlighting the impact of higher brand and marketing investments on margins. In the June quarter, the company reported revenue growth of 11.8% to ₹1,603 crore and a 7% rise in net profit to ₹343 crore. However, EBITDA margin contracted to 30.1% from 31.6% a year earlier, reflecting elevated advertising spends aimed at driving premiumisation and volume growth.

See More

News & Events

Frequently Asked Questions

What is the share price of Colgate-Palmolive (India) Ltd.?

What is the market cap of Colgate-Palmolive (India) Ltd.?

Should I buy Colgate-Palmolive (India) Ltd. stock now?

What is the 52 week high and low of Colgate-Palmolive (India) Ltd.?

Is the Colgate-Palmolive (India) Ltd. stock good to buy?

Is Colgate-Palmolive (India) Ltd. a good buy for the long term?

Is Colgate-Palmolive (India) Ltd. overvalued or undervalued?

What is the PE and PB ratio of Colgate-Palmolive (India) Ltd.?

Start Now